Cardiff Oncology Inc
NASDAQ:CRDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Golden Ponder Holdings Ltd
HKEX:1783
|
HK |
During the last 3 months Cardiff Oncology Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 2% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/crdf/vs/indx/gspc">open performance analysis).
The last transaction was made on
Jul 30, 2025
by
Pace Gary W
, who
bought
673.8k USD
worth of
CRDF shares.
During the last 3 months Cardiff Oncology Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 2% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/crdf/vs/indx/gspc">open performance analysis).
The last transaction was made on
Jul 30, 2025
by
Pace Gary W
, who
bought
673.8k USD
worth of
CRDF shares.
Cardiff Oncology Inc
Glance View
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company is headquartered in San Diego, California and currently employs 22 full-time employees. The company went IPO on 2004-07-27. The firm is focused on developing treatment for cancer patients. Its drug candidate onvansertib, is a polo-like kinase 1 (PLK1) adenosine triphosphate (ATP) competitive inhibitor with the combination of chemotherapy and targeted therapeutics. Its clinical trial includes TROV-054, CRDF-001 and TROV-053. TROV-054 is a Phase I b/2 open-label clinical trial of onvansertib in combination with FOLFIRI (folinic acid, fluorouracil, and irinotecan) and Avastin (bevacizumab). TROV-053 is a Phase II open-label clinical trial of onvansertib in combination with Zytiga (abiraterone acetate)/prednisone. CRDF-001 is a Phase 2 open-label multi-center clinical trial of onvansertib in combination with nanoliposomal irinotecan, leucovorin, and fluorouracil for second line treatment of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.